Loading…
Quest Laboratories (QUESTLAB)₹86.30+1.77%Pharmaceuticals
At the end of the Mar 2026 quarter, Quest Laboratories' shareholders were: promoters 66.82%, FIIs 0.60%, DIIs 2.05%, public 30.53%. Promoter holding is unchanged on the quarter. FII holding is down 0.70 percentage points from 1.30% a year earlier. 0.00% of promoter shares were pledged. It had 912 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Promoters | 65.87% | 65.87% | 66.25% | 66.82% | 66.82% | 66.82% |
| FIIs | 0.73% | 1.30% | 0.94% | 0.92% | 0.60% | 0.60% |
| DIIs | 4.45% | 4.87% | 2.08% | 1.40% | 1.38% | 2.05% |
| Public | 28.95% | 27.96% | 30.73% | 30.86% | 31.20% | 30.53% |
| Promoter shares pledged | — | — | — | — | — | 0.00% |
| Number of shareholders | 858 | 898 | 1,002 | 1,085 | 1,018 | 912 |
| Holder | Category | Mar 2026 | Change (pp) |
|---|---|---|---|
| Anil Kumar Sabarwal | Promoter | 62.81% | 0.00 |
| Yashvi Hitesh Patel | Public | 3.42% | New |
| Tejaswini Sabarwal | Promoter | 2.57% | 0.00 |
| Harsha Venkatesh | Public | 2.37% | New |
| Dimple Kothari | Public | 1.61% | New |
| Vinayak Sabarwal | Promoter | 1.39% | 0.00 |
| Sunil Kumar Chhabra | Public | 1.09% | New |
| Sandeep Kothari | Public | 1.07% | New |
Promoters held 66.82% of Quest Laboratories at the end of the Mar 2026 quarter, up 0.95 percentage points from 65.87% a year earlier.
In the Mar 2026 quarter, foreign institutional investors (FIIs) held 0.60% (unchanged at 0.60% a quarter earlier) and domestic institutions (DIIs) held 2.05% (up 0.67 percentage points from 1.38% a quarter earlier).
No. The Mar 2026 filing shows no pledged promoter shares.
Quest Laboratories had 912 shareholders at the end of the Mar 2026 quarter, against 898 a year earlier.
Yashvi Hitesh Patel (Public) held 3.42% at the end of the Mar 2026 quarter, the largest named holding outside the promoter group.